ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Brian R. Weston
Matched on ORCID iD 0000-0002-9872-1687; OpenAlex author ID A5070234451.
Their work
- Papers
- 9
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Collaborators
- 55
2012: 1 trial · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers
Papers 9
- Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB. Co-author DOI 10.1002/cncy.22533↗
- 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci151604↗
- Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples. Co-author DOI 10.1158/1078-0432.ccr-20-2667↗
- Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Co-author DOI 10.1158/1078-0432.ccr-20-3925↗
- Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Co-author DOI 10.4103/eus.eus_56_19↗
- Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1200/po.19.00001↗
- First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-018-6807-9↗
- Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Co-author DOI 10.1016/j.gie.2017.12.019↗
- Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. Co-author DOI 10.1007/s11605-016-3265-1↗
Trials 1
- Comparison of a Novel 22-gauge Core Biopsy Needle Principal investigator NCT01598194↗
Closest collaborators
The 25 strongest of 55 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Anirban Maitra · 8 shared papers, 2017–2022
- Paper Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopi… DOI 10.1002/cncy.22533↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiratio… DOI 10.1158/1078-0432.ccr-20-2667↗
- Manoop S. Bhutani · 7 shared papers, 2017–2022
- Paper Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopi… DOI 10.1002/cncy.22533↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiratio… DOI 10.1158/1078-0432.ccr-20-2667↗
- Jeffrey H. Lee · 6 shared papers, 2017–2022
- Paper Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopi… DOI 10.1002/cncy.22533↗
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Pancreatic cancer screening in high-risk individuals with germline genetic mutations. DOI 10.1016/j.gie.2017.12.019↗
- Matthew H. G. Katz · 5 shared papers, 2017–2022
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Quality of life impact of EUS in patients at risk for developing pancreatic cancer. DOI 10.4103/eus.eus_56_19↗
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Huamin Wang · 4 shared papers, 2017–2022
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Robert A. Wolff · 4 shared papers, 2017–2022
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Eugene Jon Koay · 4 shared papers, 2017–2022
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Jeffrey E. Lee · 4 shared papers, 2017–2022
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- William A. Ross · 3 shared papers, 2017–2022
- Paper Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopi… DOI 10.1002/cncy.22533↗
- Paper Pancreatic cancer screening in high-risk individuals with germline genetic mutations. DOI 10.1016/j.gie.2017.12.019↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Jason B. Fleming · 3 shared papers, 2017–2022
- Paper 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. DOI 10.1172/jci151604↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Alexander Semaan · 2 shared papers, 2021
- Paper Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiratio… DOI 10.1158/1078-0432.ccr-20-2667↗
- Paper Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-w… DOI 10.1158/1078-0432.ccr-20-3925↗
- Maria E. Monberg · 2 shared papers, 2021
- Paper Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiratio… DOI 10.1158/1078-0432.ccr-20-2667↗
- Paper Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-w… DOI 10.1158/1078-0432.ccr-20-3925↗
- Jaewon James Lee · 2 shared papers, 2021
- Paper Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiratio… DOI 10.1158/1078-0432.ccr-20-2667↗
- Paper Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-w… DOI 10.1158/1078-0432.ccr-20-3925↗
- Paola A. Guerrero · 2 shared papers, 2021
- Paper Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiratio… DOI 10.1158/1078-0432.ccr-20-2667↗
- Paper Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-w… DOI 10.1158/1078-0432.ccr-20-3925↗
- Vincent Bernard · 2 shared papers, 2021
- Paper Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiratio… DOI 10.1158/1078-0432.ccr-20-2667↗
- Paper Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-w… DOI 10.1158/1078-0432.ccr-20-3925↗
- Emmanuel S. Coronel · 2 shared papers, 2018–2022
- Florencia M. McAllister · 2 shared papers, 2020–2022
- Rachna T. Shroff · 3 shared papers, 2017–2019
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Milind M. Javle · 3 shared papers, 2017–2019
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Eric Peter Tamm · 3 shared papers, 2017–2019
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- David R. Fogelman · 3 shared papers, 2017–2019
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Laura R. Prakash · 3 shared papers, 2017–2019
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Priya Bhosale · 3 shared papers, 2017–2019
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Gauri Rajani Varadhachary · 3 shared papers, 2017–2019
- Paper First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-018-6807-9↗
- Paper Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for B… DOI 10.1200/po.19.00001↗
- Paper Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Exper… DOI 10.1007/s11605-016-3265-1↗
- Ching-Wei David Tzeng · 2 shared papers, 2019–2022
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.